公告日期：2024-04-26

Joincare Pharmaceutical Group Industry Co., Ltd. 2024 First Quarterly Report

Stock Code: 600380 Stock Short Name: 健康元

Joincare Pharmaceutical Group Industry Co., Ltd.

2024 First Quarterly Report

The Board of Directors and all Directors of the Company herebywarrant that there are no false

representations, misleading statements or material omissions contained in this announcement and

accept legal responsibility for the truthfulness, accuracy and completeness of the contents hereof.

IMPORTANT NOTICE:

The Board of Directors, the Board of Supervisors and Directors, Supervisors and senior management

of the Company hereby warrant the truthfulness, accuracy and completeness of the contents of this

quarterly report, and that there are no false representations, misleading statements or material

omissions contained herein, and severally and jointly accept legal responsibility.

The person-in-charge of the Company, the person-in-charge of accounting work and the person-in-

charge of the accounting department (the head of the accounting department) hereby warrant the

truthfulness,accuracyandcompletenessofthefinancialinformationcontainedinthisquarterlyreport.

Whether the first quarterly financial statements have been audited.

□Yes √No

I. MAJOR FINANCIAL DATA

(I) Major Accounting Data and Financial Indicators

Unit: Yuan Currency: RMB

Item The Reporting Period YoY change (%)

(From January to March)

Revenues 4,339,814,452.16 -4.81

Net profit attributable to shareholders 439,798,106.55 -4.96
of the listed company
Net profit attributable to shareholders……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。